Patients with autoimmune hepatitis have no increased long-term risk for psychiatric disorders compared with the general population.

Please provide your email address to receive an email when new articles are posted on . MMF demonstrated comparable safety and greater reductions in AST and ALT vs. azathioprine in autoimmune ...

Autoimmune hepatitis affects a diverse group of patients, and medical management is largely successful in controlling progression and prolonging survival. Alternative agents such as MMF have yet to ...

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible.

Autoimmune hepatitis (AIH) is a complex, chronic inflammatory liver disorder in which the body's immune system aberrantly targets hepatocytes, leading to progressive hepatic injury. Characterised by ...

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, speaks with Healio about findings from a systemic ...

Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

A Kelowna woman who has garnered significant news coverage in her quest to get a liver transplant is nearing death.

FDA placed Kezar’s lupus nephritis drug on clinical hold after four fatal adverse events. Kezar says the autoimmune hepatitis trial remains unaffected. Feel unsure about the market’s next move? Copy ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...

Good day, everyone. My name is Mitchell, and I will be your conference operator today. At this time, I would like to welcome you to Kezar Life Sciences 2025 Topline Data Presentation of the PORTOLA ...